{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:21:04Z","timestamp":1790050864618,"version":"4.0.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.ophtha.2022.01.016","type":"journal-article","created":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T03:37:27Z","timestamp":1642995447000},"page":"679-693","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Mutational Landscape and Outcomes of Conjunctival Melanoma in 101 Patients"],"prefix":"10.1016","volume":"129","author":[{"given":"Sara E.","family":"Lally","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana","family":"Milman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9460-2587","authenticated-orcid":false,"given":"Marlana","family":"Orloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren A.","family":"Dalvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles G.","family":"Eberhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Heaphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto J.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9679-4287","authenticated-orcid":false,"given":"Chun-Chieh","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip W.","family":"Dockery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry A.","family":"Shields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol L.","family":"Shields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2022.01.016_bib1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1586\/17469899.2014.921119","article-title":"Management of conjunctival malignant melanoma: a review and update","volume":"9","author":"Wong","year":"2014","journal-title":"Expert Rev Opthalmol"},{"key":"10.1016\/j.ophtha.2022.01.016_bib2","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S0002-9394(02)02288-2","article-title":"Conjunctival melanoma: is it increasing in the United States?","volume":"135","author":"Yu","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2022.01.016_bib3","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.ajo.2003.09.009","article-title":"Conjunctival melanoma: is it increasing in the United States?","volume":"136","author":"Tuomaala","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2022.01.016_bib4","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1136\/bjo.2009.157933","article-title":"Time trends in the incidence of conjunctival melanoma in Sweden","volume":"93","author":"Triay","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2022.01.016_bib5","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ophtha.2010.06.021","article-title":"Conjunctival melanoma: outcomes based on tumor origin in 382 consecutive cases","volume":"118","author":"Shields","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2022.01.016_bib6","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1177\/1120672120970393","article-title":"Conjunctival melanoma: risk factors for recurrent or new tumor in 540 patients at a single ocular oncology center","volume":"31","author":"Vaidya","year":"2021","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ophtha.2022.01.016_bib7","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1007\/s00417-019-04342-x","article-title":"Pigmentation of conjunctival melanoma recurrences and outcome","volume":"257","author":"Brouwer","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2022.01.016_bib8","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/IOP.0000000000001624","article-title":"Conjunctival melanoma: features and outcomes based on the Fitzpatrick skin type in 540 patients at a single ocular oncology center","volume":"36","author":"Shields","year":"2020","journal-title":"Ophth Plast Reconstr Surg"},{"key":"10.1016\/j.ophtha.2022.01.016_bib9","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/ICO.0000000000002449","article-title":"Conjunctival melanoma: outcomes based on age at presentation in 629 patients at a single ocular oncology center","volume":"40","author":"Dalvin","year":"2021","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2022.01.016_bib10","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/APO.0000000000000343","article-title":"Conjunctival melanoma: outcomes based on the American Joint Committee on Cancer clinical classification (8th edition) of 425 patients at a single ocular oncology center","volume":"10","author":"Shields","year":"2020","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"3","key":"10.1016\/j.ophtha.2022.01.016_bib11","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41433-021-01508-y","article-title":"Conjunctival melanoma: outcomes based on tumor origin in 629 patients at a single ocular oncology center","volume":"36","author":"Pacheco","year":"2022","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ophtha.2022.01.016_bib12","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/pcmr.12767","article-title":"Conjunctival melanoma copy number alterations and correlation with mutation status, tumor features and clinical outcomes","volume":"32","author":"Kenawy","year":"2019","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.ophtha.2022.01.016_bib13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0165-4608(02)00868-3","article-title":"Chromosomal gains and losses in ocular melanoma detected by comparative genomic hybridization in an Australian population-based study","volume":"144","author":"Vajdic","year":"2003","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.ophtha.2022.01.016_bib14","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0165-4608(96)00405-0","article-title":"Assessment of chromosome 3 copy number in ocular melanoma using fluorescence in situ hybridization","volume":"98","author":"McNamara","year":"1997","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.ophtha.2022.01.016_bib15","doi-asserted-by":"crossref","first-page":"6180","DOI":"10.1167\/iovs.10-5677","article-title":"Lack of oncogenic GNAQ mutations in melanocytic lesions of the conjunctiva as compared to uveal melanoma","volume":"51","author":"Dratviman-Storobinsky","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2022.01.016_bib16","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1001\/jamaophthalmol.2019.4237","article-title":"Integrative exome and transcriptome analysis of conjunctival melanoma and its potential application for personalized therapy","volume":"137","author":"Demirci","year":"2019","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2022.01.016_bib17","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/s41416-018-0046-5","article-title":"NF1mutations in conjunctival melanoma","volume":"118","author":"Scholz","year":"2018","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ophtha.2022.01.016_bib18","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1158\/1078-0432.CCR-13-0163","article-title":"Conjunctival melanomas harbor BRAF and NRAS mutations and copy number changes similar to cutaneous and mucosal melanomas","volume":"19","author":"Griewank","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ophtha.2022.01.016_bib19","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1167\/iovs.04-0093","article-title":"BRAF mutations in conjunctival melanoma","volume":"45","author":"Gear","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2022.01.016_bib20","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/00008390-200412000-00003","article-title":"BRAF mutations are detectable in conjunctival but not uveal melanomas","volume":"14","author":"Spendlove","year":"2004","journal-title":"Melanoma Res"},{"key":"10.1016\/j.ophtha.2022.01.016_bib21","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1001\/jamaophthalmol.2017.4837","article-title":"Molecular characteristics of conjunctival melanoma using whole-exome sequencing","volume":"135","author":"Swaminathan","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2022.01.016_bib22","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/bjc.2013.312","article-title":"TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumours","volume":"109","author":"Griewank","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ophtha.2022.01.016_bib23","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nature23306","article-title":"Integrative clinical genomics of metastatic cancer","volume":"548","author":"Robinson","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ophtha.2022.01.016_bib24","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1097\/IOP.0000000000000833","article-title":"Conjunctival melanoma response to combined systemic BRAF\/MEK inhibitors","volume":"33","author":"Dagi Glass","year":"2016","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"10.1016\/j.ophtha.2022.01.016_bib25","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1186\/s12885-016-2657-7","article-title":"A\u00a0case report of a patient with metastatic ocular melanoma who experienced a response to treatment with the BRAF inhibitor vemurafenib","volume":"16","author":"Maleka","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ophtha.2022.01.016_bib26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000452473","article-title":"Systemic BRAF\/MEK inhibitors as a potential treatment option in metastatic conjunctival melanoma","volume":"3","author":"Mor","year":"2016","journal-title":"Ocul Oncol Pathol"},{"key":"10.1016\/j.ophtha.2022.01.016_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1009201","article-title":"Genomic and transcriptomic landscape of conjunctival melanoma","volume":"16","author":"Cisarova","year":"2020","journal-title":"PloS Genet"},{"key":"10.1016\/j.ophtha.2022.01.016_bib28","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1038\/jid.2014.45","article-title":"Decreased expression of the chromatin remodeler ATRX associates with melanoma progression","volume":"134","author":"Qadeer","year":"2014","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.ophtha.2022.01.016_bib29","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.3389\/fonc.2020.01707","article-title":"Telomere maintenance associated mutations in the genetic landscape of gynecological mucosal melanoma","volume":"10","author":"Yuan","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.ophtha.2022.01.016_bib30","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.ajpath.2011.06.018","article-title":"Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes","volume":"179","author":"Heaphy","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ophtha.2022.01.016_bib31","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1158\/1541-7786.MCR-20-0839","article-title":"Meta-analysis and systemic review of the genomics of mucosal melanoma","volume":"19","author":"Broit","year":"2021","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.ophtha.2022.01.016_bib32","series-title":"Eyelid, Conjunctival and Orbital Tumors: An Atlas and Textbook","first-page":"332","article-title":"Chapter 19: Conjunctival melanocytic lesions","author":"Shields","year":"2016"},{"key":"10.1016\/j.ophtha.2022.01.016_bib33","series-title":"AJCC Cancer Staging Manual","year":"2017"},{"key":"10.1016\/j.ophtha.2022.01.016_bib34","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1126\/science.1207313","article-title":"Altered telomeres in tumors with ATRX and DAXX mutations","volume":"333","author":"Heaphy","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.ophtha.2022.01.016_bib35","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/modpathol.2017.23","article-title":"SF3B1 and BAP1 mutations in blue nevus-like melanoma","volume":"30","author":"Griewank","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ophtha.2022.01.016_bib36","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.ophtha.2018.12.047","article-title":"Genetic profiling of primary orbital melanoma: an analysis of 6 cases with clinicopathologic correlation","volume":"126","author":"Mudhar","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2022.01.016_bib37","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/aos.13007","article-title":"BRAF mutations in conjunctival melanoma: investigation of incidence, clinicopathological features, prognosis and paired premalignant lesions","volume":"94","author":"Larsen","year":"2016","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.ophtha.2022.01.016_bib38","doi-asserted-by":"crossref","first-page":"100971","DOI":"10.1016\/j.preteyeres.2021.100971","article-title":"Conjunctival melanoma: new insights in tumour genetics and immunology, leading to new therapeutic options","volume":"86","author":"Brouwer","year":"2022","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.ophtha.2022.01.016_bib39","doi-asserted-by":"crossref","first-page":"5784","DOI":"10.3390\/ijms22115784","article-title":"Molecular genetics of conjunctival melanoma and prognostic value of TERT promoter mutation analysis","volume":"22","author":"van Poppelen","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ophtha.2022.01.016_bib40","doi-asserted-by":"crossref","first-page":"3836","DOI":"10.3390\/cancers13153836","article-title":"Definition of biologically distinct groups of conjunctival melanomas according to etiological factors and implications for precision medicine","volume":"13","author":"Gardrat","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ophtha.2022.01.016_bib41","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/bjd.18947","article-title":"GNAQ and GNA11 mutant nonuveal melanoma: a subtype distinct from both cutaneous and uveal melanoma","volume":"183","author":"Livingstone","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ophtha.2022.01.016_bib42","doi-asserted-by":"crossref","first-page":"930","DOI":"10.18632\/oncotarget.26584","article-title":"Recurrent hotspot SF3B1 mutations at codon 625 in vulvovaginal mucosal melanoma identified in a study of 27 Australian mucosal melanomas","volume":"10","author":"Quek","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/j.ophtha.2022.01.016_bib43","doi-asserted-by":"crossref","first-page":"29080","DOI":"10.18632\/oncotarget.16175","article-title":"Loss of nuclear BAP1 expression is associated with poor prognosis in oral mucosal melanoma","volume":"8","author":"Song","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ophtha.2022.01.016_bib44","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/DAD.0000000000001259","article-title":"Utility of TERT promoter mutations for cutaneous primary melanoma diagnosis","volume":"41","author":"Thomas","year":"2019","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.ophtha.2022.01.016_bib45","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature10833","article-title":"Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma","volume":"482","author":"Schwartzentruber","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ophtha.2022.01.016_bib46","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/bpa.12646","article-title":"Alternative lengthening of telomeres, ATRX loss and H3-K27M mutations in histologically defined pilocytic astrocytoma with anaplasia","volume":"29","author":"Rodriguez","year":"2019","journal-title":"Brain Pathol"},{"key":"10.1016\/j.ophtha.2022.01.016_bib47","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1136\/bjophthalmol-2020-317405","article-title":"Prognostic value of TERT promoter mutations in conjunctival melanomas in addition to clinicopathological features","volume":"105","author":"van Ipenburg","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2022.01.016_bib48","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3390\/cells9030749","article-title":"The solo play of TERT promoter mutations","volume":"9","author":"Hafezi","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ophtha.2022.01.016_bib49","doi-asserted-by":"crossref","first-page":"101173","DOI":"10.1016\/j.tranon.2021.101173","article-title":"Capitalizing on ATRX loss in glioma via PARP inhibition: Comment on \"Loss of ATRX confers DNA repair defects and PARP inhibitor sensitivity\" by Garbarino et\u00a0al","volume":"14","author":"Zalenski","year":"2021","journal-title":"Transl Oncol"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642022000689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642022000689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:11:24Z","timestamp":1758982284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642022000689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0161642022000689"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2022.01.016","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mutational Landscape and Outcomes of Conjunctival Melanoma in 101 Patients","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2022.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}